Published in J Pharm Sci on May 01, 1979
Binding of drugs by albumin and plasma protein. J Pharm Sci (1977) 1.31
Effect of pH on the binding of theophylline to serum proteins. Am Rev Respir Dis (1979) 1.18
Pharmacokinetics and bioavailability of hydromorphone following intravenous and oral administration to human subjects. J Clin Pharmacol (1981) 1.07
Intraoperative serum and tissue activity of cefazolin and cefoxitin. Arch Surg (1985) 1.01
Plasma levels of clobazam after three oral dosage forms in health subjects. J Clin Pharmacol (1978) 0.95
Treatment of severe La Crosse encephalitis with intravenous ribavirin following diagnosis by brain biopsy. Pediatrics (1997) 0.94
Absorption of polyethylene glycol after administration of a PEG-electrolyte lavage solution. Clin Pharm (1986) 0.94
Intraoperative serum concentrations of cefazolin and cefoxitin administered preoperatively at different times. Clin Pharm (1984) 0.92
Plasma level studies of penbutolol after oral dose in man. J Clin Pharmacol (1977) 0.83
Comparison of graphical and computerized methods for calculating binding parameters for two strongly bound drugs to human serum albumin. J Pharm Sci (1976) 0.83
Buffer and pH effects on propranolol binding by human albumin and alpha 1-acid glycoprotein. J Pharm Pharmacol (1988) 0.83
Sterically stabilized liposomes in cancer therapy and gene delivery. Curr Opin Mol Ther (1999) 0.83
Clearance of serum cortisol in suckled and nonsuckled postpartum beef cows. J Anim Sci (1981) 0.80
Cephalosporins for surgical prophylaxis: computer projections of intraoperative availability. South Med J (1985) 0.80
Intraoperative ceforanide pharmacokinetics and protein binding. Antimicrob Agents Chemother (1985) 0.79
Analysis of fluorescence quenching data by the method of Levine. Clin Chem (1980) 0.78
Mefenamic acid, chlormezanone-paracetamol, ethoheptazine-aspirin-meprobamate: a comparative study in acute low back pain. Br J Clin Pract (1987) 0.77
Interaction of dantrolene sodium with human serum albumin. J Pharm Sci (1976) 0.76
Evaluation of the performance of controlled release dosage forms of ticlopidine using in vitro intestinal permeability and computer simulations. J Drug Target (1994) 0.75
Plasma levels of clobazam after 10-, 20-, and 40-mg tablet doses in healthy subjects. J Clin Pharmacol (1980) 0.75
Interaction of sulindac and metabolite with human serum albumin. J Pharm Sci (1978) 0.75
Fluorescence stability of human albumin solutions. J Pharm Sci (1982) 0.75
Interaction of the antimalarial alpha-dibutylaminomethyl-2,6-bis(trifluoromethylphenyl)-4-pyridinemethanol with human serum albumin. J Pharm Sci (1979) 0.75
Effect of bile salts on partitioning behavior and GI absorption of a quaternary ammonium compound, isopropamide iodide. J Pharm Sci (1973) 0.75
Avascular necrosis of the proximal humeral epiphysis after physeal fracture. A case report. J Bone Joint Surg Am (1997) 0.75
Enhancement of transdermal delivery of phenylbutazone from liposomal gel formulations through deer skin. J Vet Pharmacol Ther (2009) 0.75
Binding of xanthine derivatives to human serum albumin as a function of pH. Acta Pharm Suec (1981) 0.75
Pharmacokinetics of tiazofurin in dogs. Biopharm Drug Dispos (1987) 0.75
Human albumin binding of tamoxifen in the presence of a perfluorochemical erythrocyte substitute. J Pharm Pharmacol (1991) 0.75
A new method for the determination of the site binding constant of each species of a partially ionized drug. Acta Pharm Suec (1980) 0.75
Effect of a perfluorochemical emulsion on prednisolone binding by human albumin. Biochem Pharmacol (1986) 0.75
Binding of warfarin by human albumin in the presence of a perfluorochemical blood substitute. Arch Int Pharmacodyn Ther (1985) 0.75
Circular dichroic examination of the interaction of some planar acidic drugs with tryptophan-modified human serum albumin. J Pharm Pharmacol (1981) 0.75
Influence of respiratory acidosis and alkalosis on volume of distribution of theophylline in dogs. Res Commun Chem Pathol Pharmacol (1979) 0.75
An unbiased method for estimating binding parameters in a non-cooperative binding process. Biochim Biophys Acta (1974) 0.75
Aggregation of dantrolene to human serum albumin. J Pharm Sci (1978) 0.75
beta-Lipoproteins: possible plasma transport proteins for basic drugs. J Pharm Sci (1977) 0.75
Effects of a perfluorochemical emulsion on L-tryptophan binding by human albumin. Arch Int Pharmacodyn Ther (1990) 0.75
Some quantitative investigations of the binding to and the displacement of bishydroxycoumarin from human serum albumin. Biochem Pharmacol (1975) 0.75
Plasma level profiles and clinical response of penbutolol after three different single oral doses in man. J Clin Pharmacol (1979) 0.75
Liquid chromatography in pharmaceutical analysis VI: determination of dantrolene sodium in a dosage form. J Pharm Sci (1977) 0.75
Cardiac rhythm disturbances during fiberoptic bronchoscopy: a prospective study. J Thorac Cardiovasc Surg (1979) 0.75
Bioavailability of regular and controlled-release chlorpheniramine products. J Pharm Sci (1982) 0.75
Effect of albumin conformation on binding of phenylbutazone and oxyphenbutazone to human serum albumin. J Pharm Sci (1982) 0.75
Perfluorochemical emulsion effect on warfarin binding by fraction V human albumin. Arch Int Pharmacodyn Ther (1987) 0.75
Perfluorochemical erythrocyte substitutes: disposition and effects on drug distribution and elimination. Drug Metab Rev (1991) 0.75
Effects of a perfluorochemical blood substitute on diazepam binding by human albumin. J Pharm Pharmacol (1988) 0.75
The effect of protein concentration on the binding of sulfamethoxypyridazine by human and bovine serum albumin. Arch Int Pharmacodyn Ther (1980) 0.75
Furosemide binding by human albumin: comparison of two methods of fluorescence quenching analysis. J Pharm Sci (1983) 0.75
The absorption and distribution of isopropamide iodide in the rat. J Pharm Pharmacol (1973) 0.75
Examination of blood clobazam levels and several pupillary measures in humans. J Pharm Sci (1979) 0.75
Indomethacin release from silicone rubber: a suggested method for continuous inhibition of prostaglandin synthesis. Res Commun Chem Pathol Pharmacol (1975) 0.75
Blood levels following multiple oral dosing of chlorpheniramine conventional and controlled release preparations. Biopharm Drug Dispos (1982) 0.75
Human plasma levels of propranolol: fluorometric measurement in a hydrosolvatic system. J Pharm Sci (1980) 0.75
Pharmacodynamics of acute intranasal administration of verapamil: comparison with i.v. and oral administration. Biopharm Drug Dispos (1986) 0.75
A contact detection system for identifying individual animals in groups. Physiol Behav (1972) 0.75
Preliminary investigations of intrinsic and extrinsic optical activity as purity criterion for human serum albumins. J Pharm Sci (1975) 0.75
Scatchard plot analysis of ligand--erythrocyte interactions. J Pharm Sci (1978) 0.75
Limitations of fluorescence quenching data analysis in dantrolene binding by human albumin. Pharm Acta Helv (1987) 0.75
Effect of bile salts on partitioning and oral toxicity of the bisquaternary ammonium drug decamethonium bromide. J Pharm Sci (1974) 0.75
Prazosin alters free and total plasma digoxin levels in dogs. Am Heart J (1985) 0.75
Loss of propranolol during ultrafiltration in plasma protein binding studies. Res Commun Chem Pathol Pharmacol (1986) 0.75
Age-related changes in the pharmacodynamics of verapamil. Am Heart J (1985) 0.75
Liquid chromatography in pharmaceutical analysis VII: determination of dantrolene sodium in biological fluids. J Pharm Sci (1977) 0.75
The effect of the anion on the absorption of tetracycline from the rat stomach. J Pharm Pharmacol (1970) 0.75